{"id":72005,"title":"[Oncoplastic versus conventional breast conserving surgery. A comparison of clinicopathological findings, cosmetic results and quality of life in 60 cases].","abstract":"Az onkoplasztikus sebészi technikák látszanak elõször alkalmasnak arra, hogy évtizedes célokat megvalósítva a tumor radikális eltávolítása mellett kozmetikailag értékes emlõt õrizzenek meg. A jelen vizsgálat célja a hagyományos (BCS), illetve onkoplasztikus (OPS) emlõmegtartó mûtétek klinikopatológiai összehasonlítása, kiegészítve a betegek szubjektív kozmetikai és életminõség-értékelésével, magyar beteganyagon elõször. A vizsgálat korai emlõrákoknál egy sebész által végzett 60 emelt szintû onkoplasztikus és 60 hagyományos emlõmegtartó mûtéttel kezelt eset retrospektív klinikopatológiai adatfeldolgozását, valamint az adjuváns radioterápiát követõen a betegek szubjektív kozmetikai és életminõség-felmérését (EORTC BR23) végezte. Az eredmények összehasonlítása statisztikai módszerekkel történt. A két csoportban az életkor, a tumorok elhelyezkedése, az emlõk mérete, az axilláris mûtétek típusa (õrszemnyirokcsomó-biopszia vs. axilláris lymphadenectomia), a grade, a receptorstátusz érdemben nem tért el. Az OPS csoportban szignifikánsan nagyobb volt a tumorméret (p=0,0009), több volt a kvadrantektómia (p=0,0032), gyakoribb volt a regionális nyirokcsomóáttét (p=0,0043) és az adjuváns kemoterápia (p=0,0122). Az OPS csoportban a mûtéti idõ hosszabb (p<0,001), a specimen tömege nagyobb (p=0,0308), a mikroszkóposan pozitív szél és emiatt a komplettáló mûtétek aránya (p=0,0306) szignifikánsan kisebb volt, mint a BCS csoportban. Nem volt különbség a két csoport között a szövõdmények arányában és az adjuváns kezelés megkezdéséig eltelt idõben. A kozmetikai eredmény az OPS csoportban egyértelmûen jobb volt (p<0,001), kevesebb volt a kar- és váll- (p=0,0399), illetve az adott oldali mellkasfali fájdalom (p=0,0304) és jobb volt az operált oldali felsõ végtag mozgása (p=0,006). Az OPS csoport rövid átlagos utánkövetési ideje (BCS átlag 32,2 hónap vs. OPS átlag 8,7 hónap) nem tette lehetõvé az onkológiai végpontok érdemi megítélését. Az onkoplasztikus mûtétek a hagyományos emlõmegtartó sebészethez képest, bár hosszabb mûtéti idõvel, de nagyobb tumoroknál is lehetõséget adnak a mikroszkóposan radikális daganateltávolításra, valódi kvadrantektómiákra, magasabb szövõdményarány nélkül, nem késleltetve az adjuváns kezeléseket, nem fokozva ezzel az onkológiai kockázatot. Emellett az OPS mûtétek jobb kozmetikai eredményt és magasabb betegelégedettséget biztosítanak, mint a hagyományos BCS mûtétek. Az OPS mûtétekkel elérhetõ helyi daganatmentesség pontos megítéléséhez nagyobb esetszám és hosszabb utánkövetési idõ szükséges.Oncoplastic surgical techniques seem to be suitable for realizing the goal of retaining cosmesis following radical removal of breast tumors. The purpose of the present study is to provide a clinical and pathological comparison of conventional (BCS) and oncoplastic (OPS) breast-conserving surgeries, supplemented by a subjective assessment of cosmesis and quality of life of patients, the first time on a Hungarian sample. The authors performed a retrospective assessment of clinicopathological data of 60 advanced oncoplastic and 60 conventional breast-conserving surgery cases, and following adjuvant radiotherapy, the authors also surveyed patients for cosmetic results and quality of life (EORTC BR23). Comparison of the results was performed by statistical methods. The two groups did not differ substantially in age, tumor location, breast size, type of axillary surgery (sentinel node biopsy vs. axillary lymphadenectomy), tumor grade and receptor status. Tumor size was significantly greater (p=0.0009), the rate of quadranectomies was higher (p=0.0032), metastases in the regional lymph nodes (p=0.0043) and the administration of adjuvant chemotherapy (p=0.0122) were more frequent in the OPS group. The duration of surgeries was longer (p<0.001), the weight of the specimens was greater (p=0.0308), the rate of completion surgeries due to microscopically positive surgical margins was significantly smaller (p=0.0306) in the OPS than in the BCS group. There was no difference between the two groups in the rate of complications and the time elapsed to the start of adjuvant treatment. The cosmetic outcome was clearly superior in the OPS group (p<0.001), and OPS patients had fewer arm, shoulder (p=0.0399), and chest pain (of the affected side) (p=0.0304), upper limb movements of the operated side were also better (p=0.006). The short follow-up period of the OPS group (mean 32.2 vs. 8.7 months in BCS and OPS, respectively) did not allow a meaningful assessment of oncologic endpoints. When compared to conventional breast conserving surgery, oncoplastic surgery is suitable for microscopically radical tumor removal even in case of larger lesions and true quadranectomy with longer surgical time but lower rate of complications without delaying the adjuvant treatments and thus not increasing the cancer risk. OPS yields better cosmetic results and higher patient satisfaction compared to BCS. More experience and longer follow-up is needed for the assessment of local tumor control achieved by OPS.","date":"2014-07-11","categories":"Neoplasms","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/25010760","annotations":[{"name":"Sentinel lymph node","weight":0.894932,"wikipedia_article":"http://en.wikipedia.org/wiki/Sentinel_lymph_node"},{"name":"Lymphadenectomy","weight":0.877494,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymphadenectomy"},{"name":"Radiation therapy","weight":0.829773,"wikipedia_article":"http://en.wikipedia.org/wiki/Radiation_therapy"},{"name":"Biopsy","weight":0.816757,"wikipedia_article":"http://en.wikipedia.org/wiki/Biopsy"},{"name":"Chemotherapy","weight":0.809719,"wikipedia_article":"http://en.wikipedia.org/wiki/Chemotherapy"},{"name":"Cancer","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Cancer"},{"name":"Microscope","weight":0.789253,"wikipedia_article":"http://en.wikipedia.org/wiki/Microscope"},{"name":"Surgery","weight":0.771361,"wikipedia_article":"http://en.wikipedia.org/wiki/Surgery"},{"name":"Quality of life","weight":0.767518,"wikipedia_article":"http://en.wikipedia.org/wiki/Quality_of_life"},{"name":"Pathology","weight":0.765164,"wikipedia_article":"http://en.wikipedia.org/wiki/Pathology"},{"name":"Tumor","weight":0.760203,"wikipedia_article":"http://en.wikipedia.org/wiki/Tumor"},{"name":"Pain","weight":0.750676,"wikipedia_article":"http://en.wikipedia.org/wiki/Pain"},{"name":"Breast cancer","weight":0.750676,"wikipedia_article":"http://en.wikipedia.org/wiki/Breast_cancer"},{"name":"Breast","weight":0.748309,"wikipedia_article":"http://en.wikipedia.org/wiki/Breast"},{"name":"Adjuvant","weight":0.745665,"wikipedia_article":"http://en.wikipedia.org/wiki/Adjuvant"},{"name":"Metastasis","weight":0.739806,"wikipedia_article":"http://en.wikipedia.org/wiki/Metastasis"},{"name":"Lesion","weight":0.736679,"wikipedia_article":"http://en.wikipedia.org/wiki/Lesion"},{"name":"Lymph node","weight":0.668882,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymph_node"},{"name":"Lymph","weight":0.652619,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymph"},{"name":"Oncology","weight":0.627109,"wikipedia_article":"http://en.wikipedia.org/wiki/Oncology"},{"name":"Therapy","weight":0.591594,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Adjuvant therapy","weight":0.586928,"wikipedia_article":"http://en.wikipedia.org/wiki/Adjuvant_therapy"},{"name":"Chest pain","weight":0.57086,"wikipedia_article":"http://en.wikipedia.org/wiki/Chest_pain"},{"name":"Clinical trial","weight":0.562319,"wikipedia_article":"http://en.wikipedia.org/wiki/Clinical_trial"},{"name":"EORTC","weight":0.549337,"wikipedia_article":"http://en.wikipedia.org/wiki/EORTC"},{"name":"Complication (medicine)","weight":0.515544,"wikipedia_article":"http://en.wikipedia.org/wiki/Complication_(medicine)"},{"name":"Receptor (biochemistry)","weight":0.508055,"wikipedia_article":"http://en.wikipedia.org/wiki/Receptor_(biochemistry)"},{"name":"Axilla","weight":0.469308,"wikipedia_article":"http://en.wikipedia.org/wiki/Axilla"},{"name":"Patient","weight":0.418173,"wikipedia_article":"http://en.wikipedia.org/wiki/Patient"},{"name":"Radical (chemistry)","weight":0.360144,"wikipedia_article":"http://en.wikipedia.org/wiki/Radical_(chemistry)"},{"name":"Arm","weight":0.290881,"wikipedia_article":"http://en.wikipedia.org/wiki/Arm"},{"name":"Statistics","weight":0.189122,"wikipedia_article":"http://en.wikipedia.org/wiki/Statistics"},{"name":"Cosmetics","weight":0.18053,"wikipedia_article":"http://en.wikipedia.org/wiki/Cosmetics"},{"name":"Breast cancer classification","weight":0.164972,"wikipedia_article":"http://en.wikipedia.org/wiki/Breast_cancer_classification"},{"name":"Chest","weight":0.140005,"wikipedia_article":"http://en.wikipedia.org/wiki/Chest"},{"name":"Shoulder","weight":0.134742,"wikipedia_article":"http://en.wikipedia.org/wiki/Shoulder"},{"name":"Anatomical terms of location","weight":0.0582564,"wikipedia_article":"http://en.wikipedia.org/wiki/Anatomical_terms_of_location"},{"name":"Medicine","weight":0.054746,"wikipedia_article":"http://en.wikipedia.org/wiki/Medicine"},{"name":"Grading (tumors)","weight":0.0539708,"wikipedia_article":"http://en.wikipedia.org/wiki/Grading_(tumors)"},{"name":"Hungary","weight":0.0400013,"wikipedia_article":"http://en.wikipedia.org/wiki/Hungary"},{"name":"Limb (anatomy)","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/Limb_(anatomy)"},{"name":"Risk","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/Risk"},{"name":"Mean","weight":0.0300804,"wikipedia_article":"http://en.wikipedia.org/wiki/Mean"},{"name":"On-base plus slugging","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/On-base_plus_slugging"},{"name":"Volt","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Volt"},{"name":"Upper limb","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Upper_limb"},{"name":"Weight","weight":0.0279596,"wikipedia_article":"http://en.wikipedia.org/wiki/Weight"},{"name":"Data","weight":0.0279596,"wikipedia_article":"http://en.wikipedia.org/wiki/Data"},{"name":"Brazil","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Brazil"},{"name":"Functional group","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Functional_group"},{"name":"Half-life","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Half-life"},{"name":"Evaluation","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Evaluation"},{"name":"Management","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Management"},{"name":"Id, ego and super-ego","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Id,_ego_and_super-ego"},{"name":"Surveying","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Surveying"},{"name":"Social movement","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Social_movement"},{"name":"Subjectivity","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Subjectivity"},{"name":"Specimen","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Specimen"}]}
